Literature DB >> 33444930

Persecutory ideation and anomalous perceptual experiences in the context of the COVID-19 outbreak in France: what's left one month later?

Catherine Bortolon1, Delphine Capdevielle2, Julien Dubreucq3, Stéphane Raffard4.   

Abstract

PURPOSE: Beyond the effects of the coronavirus pandemic on the public's health, the length of lockdown and its possible psychological impacts on populations is heavily debated. However, the consequences of lockdown on psychotic symptoms have been poorly investigated.
METHODS: An online survey was run from April 13 to May 11, 2020; a total of 728 French subjects from the general population were included in the study. We assessed the perceived impact of the COVID-19 outbreak, length of isolation, diagnosis/symptoms/hospitalisation related to the COVID-19 (oneself and family). Paranoid ideations and hallucination-like experiences were assessed via the Paranoia Scale and the Cardiff Anomalous Perceptions Scale, respectively. Self-reported measures of negative affect, loneliness, sleep difficulties, jumping to conclusion bias, repetitive thoughts, among others, were also included.
RESULTS: Final regression model for paranoia indicated that socio-demographic variables (age, sex and education), loneliness, cognitive bias, anxiety, experiential avoidance, repetitive thoughts and hallucinations were associated with paranoia (R2 = 0.43). For hallucinations, clinical variables as well as the quality of sleep, behavioural activation, repetitive thoughts, anxiety and paranoia were associated with hallucinations in our sample (R2 = 0.27). Neither length of isolation nor the perceived impact of the COVID-19 pandemic were associated with psychotic experiences in the final models.
CONCLUSIONS: No evidence was found for the impact of isolation on psychotic symptoms in the general population in France one month after the lockdown. It nevertheless confirms the preeminent role of several factors previously described in the maintenance and development of psychotic symptoms in the context of a pandemic and lockdown measures.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  COVID-19; Hallucinations; Isolation; Lockdown; Paranoia

Year:  2020        PMID: 33444930     DOI: 10.1016/j.jpsychires.2020.12.042

Source DB:  PubMed          Journal:  J Psychiatr Res        ISSN: 0022-3956            Impact factor:   4.791


  6 in total

1.  Cross-cultural comparisons of psychosocial distress in the USA, South Korea, France, and Hong Kong during the initial phase of COVID-19.

Authors:  Derek J Dean; Ivy F Tso; Anne Giersch; Hyeon-Seung Lee; Tatiana Baxter; Taylor Griffith; Lijun Song; Sohee Park
Journal:  Psychiatry Res       Date:  2020-11-26       Impact factor: 3.222

2.  Investigating predictors contributing to the expression of schizotypy during the COVID-19 pandemic.

Authors:  Wei Lin Toh; Philip J Sumner; Denny Meyer; Erica Neill; Andrea Phillipou; Eric J Tan; Tamsyn E Van Rheenen; Susan L Rossell
Journal:  J Psychiatr Res       Date:  2022-04-03       Impact factor: 5.250

3.  Facing the pandemic and lockdown: an insight on mental health from a longitudinal study using diaries.

Authors:  Amaury C Mengin; Melissa C Allé; Estelle Koning; Bichthuy Pham; Sohee Park; Fabrice Berna; Anne Giersch
Journal:  Schizophrenia (Heidelb)       Date:  2022-03-15

4.  Pandemic paranoia in the general population: international prevalence and sociodemographic profile.

Authors:  Lyn Ellett; Björn Schlier; Jessica L Kingston; Chen Zhu; Suzanne Ho-Wai So; Tania M Lincoln; Eric M J Morris; Brandon A Gaudiano
Journal:  Psychol Med       Date:  2022-09-06       Impact factor: 10.592

Review 5.  Loneliness in Personality Disorders.

Authors:  Matthias A Reinhard; Tabea Nenov-Matt; Frank Padberg
Journal:  Curr Psychiatry Rep       Date:  2022-10-01       Impact factor: 8.081

6.  Paranoia, hallucinations and compulsive buying during the early phase of the COVID-19 outbreak in the United Kingdom: A preliminary experimental study.

Authors:  B Lopes; C Bortolon; R Jaspal
Journal:  Psychiatry Res       Date:  2020-09-17       Impact factor: 11.225

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.